4.8 Article

An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle

Journal

ONCOGENE
Volume 27, Issue 12, Pages 1696-1704

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.onc.1210814

Keywords

FoxM1; cell cycle regulation; FoxM1-inhibitory domain; transforming activity

Funding

  1. NCI NIH HHS [R01 CA124488, CA100035, R01 CA100035, R01 CA100035-04, CA124488, CA46565, R01 CA124488-02, R01 CA046565] Funding Source: Medline
  2. NIA NIH HHS [R01 AG021842, R01 AG021842-05] Funding Source: Medline
  3. NIDDK NIH HHS [R01 DK054687, R01 DK044525, DK044525, R01 DK054687-09] Funding Source: Medline

Ask authors/readers for more resources

The FoxM1 transcription factor plays critical roles in the expression of genes that are essential for cell proliferation. FoxM1 null or depleted cells fail to progress through mitosis, as expression of several mitotic genes depends upon FoxM1. The transcriptional activity of FoxM1 is stimulated by cyclin-cdk-mediated phosphorylation at a site within the transcriptional activation domain. Here, we characterize the role of an N-terminal inhibitory domain in the transcriptional activity of FoxM1. Deletion of the N-terminal 232 amino-acid residues increases the transcriptional and transforming activities of FoxM1. Moreover, while the activity of the full-length FoxM1 is stimulated by growth factors, the activity of the N-terminal deletion mutant is constitutively high in all phases of the cell cycle. The N-terminal deletion also eliminates the requirement for cyclin-cdk to activate FoxM1. We provide evidence that the N-terminal domain interacts with the C-terminal half of the transcription factor to attenuate its transcriptional activity. Moreover, the N-terminal fragment inhibits the transcriptional activity of FoxM1 in G(1)/S cells, but not in G(2)/M cells. Our results suggest that cyclin-cdk phosphorylates FoxM1 to counteract the inhibition by the N-terminal domain to fully activate FoxM1 in G(2)/M phase.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available